International Multi-center Comparative Randomized Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2017
At a glance
- Drugs BCD 085 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Biocad
- 14 Jul 2017 Status changed from recruiting to completed.
- 06 Apr 2017 Status changed from not yet recruiting to recruiting.
- 14 Oct 2016 New trial record